CLINICAL TRIAL OF ArTiMist ANTI MALARIA TREATMENT UPDATE
Eastland Medical Systems Ltd (ASX:EMS) announces today that it has received advice from Mr. Calvin Ross R&D Director of ProtoPharma Ltd our project consultant, and newly appointed Non-Executive Director of Eastland,
following hisThird visit to Rwanda to review progress of the trial, that he notes that the enrolment rate of children for the trial has been been faster than expected,
Based on this recent review it is now expected that we will be able to inform the market on the progress and initial findings of the trial in early February 2010.
.
CLINICAL TRIAL OF ArTiMist ANTI MALARIA TREATMENT UPDATEEastland...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.394M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EMS (ASX) Chart |
Day chart unavailable